483 Rentschler Biopharma SE May 2017

483 Rentschler Biopharma SE May 2017

$119 - Not in Stock

FDA investigators audited the Rentschler Biopharma SE - Laupheim, Germany facility and issued inspectional observations (via FDA 483) on 23 May 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 23 May 2017
  • Location: Laupheim, Germany
  • FEI: 1000291122

Pre-Order Not Available